Logo image of RSKD

RISKIFIED LTD-A (RSKD) Stock Fundamental Analysis

NYSE:RSKD - New York Stock Exchange, Inc. - IL0011786493 - Common Stock - Currency: USD

5.07  +0.07 (+1.4%)

After market: 5.07 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to RSKD. RSKD was compared to 283 industry peers in the Software industry. RSKD has a great financial health rating, but its profitability evaluates not so good. RSKD is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year RSKD was profitable.
RSKD had a positive operating cash flow in the past year.
In the past 5 years RSKD always reported negative net income.
In multiple years RSKD reported negative operating cash flow during the last 5 years.
RSKD Yearly Net Income VS EBIT VS OCF VS FCFRSKD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

RSKD has a Return On Assets (-7.04%) which is in line with its industry peers.
RSKD's Return On Equity of -9.13% is in line compared to the rest of the industry. RSKD outperforms 51.24% of its industry peers.
Industry RankSector Rank
ROA -7.04%
ROE -9.13%
ROIC N/A
ROA(3y)-11.33%
ROA(5y)-14.01%
ROE(3y)-14.06%
ROE(5y)-17.14%
ROIC(3y)N/A
ROIC(5y)N/A
RSKD Yearly ROA, ROE, ROICRSKD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

RSKD's Gross Margin of 52.24% is on the low side compared to the rest of the industry. RSKD is outperformed by 65.37% of its industry peers.
RSKD's Gross Margin has been stable in the last couple of years.
RSKD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.91%
GM growth 5Y0.76%
RSKD Yearly Profit, Operating, Gross MarginsRSKD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

9

2. Health

2.1 Basic Checks

RSKD does not have a ROIC to compare to the WACC, probably because it is not profitable.
RSKD has less shares outstanding than it did 1 year ago.
RSKD has more shares outstanding than it did 5 years ago.
RSKD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
RSKD Yearly Shares OutstandingRSKD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
RSKD Yearly Total Debt VS Total AssetsRSKD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

RSKD has an Altman-Z score of 4.24. This indicates that RSKD is financially healthy and has little risk of bankruptcy at the moment.
RSKD has a better Altman-Z score (4.24) than 65.37% of its industry peers.
There is no outstanding debt for RSKD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.24
ROIC/WACCN/A
WACC9.09%
RSKD Yearly LT Debt VS Equity VS FCFRSKD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 6.15 indicates that RSKD has no problem at all paying its short term obligations.
With an excellent Current ratio value of 6.15, RSKD belongs to the best of the industry, outperforming 90.81% of the companies in the same industry.
A Quick Ratio of 6.15 indicates that RSKD has no problem at all paying its short term obligations.
RSKD has a better Quick ratio (6.15) than 90.81% of its industry peers.
Industry RankSector Rank
Current Ratio 6.15
Quick Ratio 6.15
RSKD Yearly Current Assets VS Current LiabilitesRSKD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

6

3. Growth

3.1 Past

RSKD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 77.78%, which is quite impressive.
RSKD shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.05%.
RSKD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.19% yearly.
EPS 1Y (TTM)77.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25%
Revenue 1Y (TTM)10.05%
Revenue growth 3Y12.65%
Revenue growth 5Y20.19%
Sales Q2Q%7.83%

3.2 Future

Based on estimates for the next years, RSKD will show a very strong growth in Earnings Per Share. The EPS will grow by 22.32% on average per year.
RSKD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.41% yearly.
EPS Next Y3.46%
EPS Next 2Y33.68%
EPS Next 3Y22.32%
EPS Next 5YN/A
Revenue Next Year4.81%
Revenue Next 2Y7.14%
Revenue Next 3Y8.41%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
RSKD Yearly Revenue VS EstimatesRSKD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
RSKD Yearly EPS VS EstimatesRSKD Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5 -2

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 31.69, which means the current valuation is very expensive for RSKD.
Based on the Price/Earnings ratio, RSKD is valued a bit cheaper than 67.84% of the companies in the same industry.
When comparing the Price/Earnings ratio of RSKD to the average of the S&P500 Index (26.60), we can say RSKD is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 16.69, the valuation of RSKD can be described as correct.
Based on the Price/Forward Earnings ratio, RSKD is valued cheaper than 81.98% of the companies in the same industry.
RSKD's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.43.
Industry RankSector Rank
PE 31.69
Fwd PE 16.69
RSKD Price Earnings VS Forward Price EarningsRSKD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of RSKD indicates a rather cheap valuation: RSKD is cheaper than 80.57% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 20.99
EV/EBITDA N/A
RSKD Per share dataRSKD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates RSKD does not grow enough to justify the current Price/Earnings ratio.
RSKD's earnings are expected to grow with 22.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)9.16
PEG (5Y)N/A
EPS Next 2Y33.68%
EPS Next 3Y22.32%

0

5. Dividend

5.1 Amount

RSKD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

RISKIFIED LTD-A

NYSE:RSKD (5/20/2025, 8:04:01 PM)

After market: 5.07 0 (0%)

5.07

+0.07 (+1.4%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-14 2025-05-14/bmo
Earnings (Next)N/A N/A
Inst Owners62.49%
Inst Owner Change-5.55%
Ins Owners16.66%
Ins Owner ChangeN/A
Market Cap819.72M
Analysts73.33
Price Target6.01 (18.54%)
Short Float %1.2%
Short Ratio2.17
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)21.6%
Min EPS beat(2)-25.54%
Max EPS beat(2)68.74%
EPS beat(4)3
Avg EPS beat(4)37.19%
Min EPS beat(4)-25.54%
Max EPS beat(4)74.84%
EPS beat(8)7
Avg EPS beat(8)71.56%
EPS beat(12)11
Avg EPS beat(12)72.76%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.25%
Min Revenue beat(2)1.48%
Max Revenue beat(2)3.03%
Revenue beat(4)2
Avg Revenue beat(4)0.63%
Min Revenue beat(4)-1.66%
Max Revenue beat(4)3.03%
Revenue beat(8)2
Avg Revenue beat(8)-0.29%
Revenue beat(12)6
Avg Revenue beat(12)0.72%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)12.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-81.8%
EPS NY rev (1m)4.41%
EPS NY rev (3m)-21.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.87%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)0.21%
Valuation
Industry RankSector Rank
PE 31.69
Fwd PE 16.69
P/S 2.5
P/FCF 20.99
P/OCF 20.65
P/B 2.14
P/tB 2.16
EV/EBITDA N/A
EPS(TTM)0.16
EY3.16%
EPS(NY)0.3
Fwd EY5.99%
FCF(TTM)0.24
FCFY4.76%
OCF(TTM)0.25
OCFY4.84%
SpS2.03
BVpS2.36
TBVpS2.35
PEG (NY)9.16
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.04%
ROE -9.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.24%
FCFM 11.93%
ROA(3y)-11.33%
ROA(5y)-14.01%
ROE(3y)-14.06%
ROE(5y)-17.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.91%
GM growth 5Y0.76%
F-Score7
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 13.05%
Cap/Sales 0.19%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.15
Quick Ratio 6.15
Altman-Z 4.24
F-Score7
WACC9.09%
ROIC/WACCN/A
Cap/Depr(3y)75.59%
Cap/Depr(5y)199.54%
Cap/Sales(3y)1.24%
Cap/Sales(5y)2.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)77.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25%
EPS Next Y3.46%
EPS Next 2Y33.68%
EPS Next 3Y22.32%
EPS Next 5YN/A
Revenue 1Y (TTM)10.05%
Revenue growth 3Y12.65%
Revenue growth 5Y20.19%
Sales Q2Q%7.83%
Revenue Next Year4.81%
Revenue Next 2Y7.14%
Revenue Next 3Y8.41%
Revenue Next 5YN/A
EBIT growth 1Y39.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year44.7%
EBIT Next 3Y57.67%
EBIT Next 5YN/A
FCF growth 1Y559.34%
FCF growth 3YN/A
FCF growth 5Y97.19%
OCF growth 1Y445.35%
OCF growth 3YN/A
OCF growth 5Y59.55%